288 related articles for article (PubMed ID: 15647250)
1. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
Haché G; Liddament MT; Harris RS
J Biol Chem; 2005 Mar; 280(12):10920-4. PubMed ID: 15647250
[TBL] [Abstract][Full Text] [Related]
2. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
Langlois MA; Beale RC; Conticello SG; Neuberger MS
Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
Liddament MT; Brown WL; Schumacher AJ; Harris RS
Curr Biol; 2004 Aug; 14(15):1385-91. PubMed ID: 15296757
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
Holmes RK; Koning FA; Bishop KN; Malim MH
J Biol Chem; 2007 Jan; 282(4):2587-95. PubMed ID: 17121840
[TBL] [Abstract][Full Text] [Related]
5. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle.
Wang X; Dolan PT; Dang Y; Zheng YH
J Biol Chem; 2007 Jan; 282(3):1585-94. PubMed ID: 17142455
[TBL] [Abstract][Full Text] [Related]
6. Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.
Jónsson SR; Haché G; Stenglein MD; Fahrenkrug SC; Andrésdóttir V; Harris RS
Nucleic Acids Res; 2006; 34(19):5683-94. PubMed ID: 17038330
[TBL] [Abstract][Full Text] [Related]
7. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
8. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
Zennou V; Bieniasz PD
Virology; 2006 May; 349(1):31-40. PubMed ID: 16460778
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
12. Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
Nagao T; Yamashita T; Miyake A; Uchiyama T; Nomaguchi M; Adachi A
J Med Invest; 2010 Feb; 57(1-2):89-94. PubMed ID: 20299747
[TBL] [Abstract][Full Text] [Related]
13. APOBEC-mediated interference with hepadnavirus production.
Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
[TBL] [Abstract][Full Text] [Related]
14. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
15. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.
Schumacher AJ; Nissley DV; Harris RS
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9854-9. PubMed ID: 16000409
[TBL] [Abstract][Full Text] [Related]
17. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
Wichroski MJ; Robb GB; Rana TM
PLoS Pathog; 2006 May; 2(5):e41. PubMed ID: 16699599
[TBL] [Abstract][Full Text] [Related]
18. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
[TBL] [Abstract][Full Text] [Related]
19. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.
Rathore A; Carpenter MA; Demir Ö; Ikeda T; Li M; Shaban NM; Law EK; Anokhin D; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2013 Nov; 425(22):4442-54. PubMed ID: 23938202
[TBL] [Abstract][Full Text] [Related]
20. Guanine-adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation.
Müller V; Bonhoeffer S
Trends Genet; 2005 May; 21(5):264-8. PubMed ID: 15851060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]